ATE422880T1 - Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen - Google Patents

Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen

Info

Publication number
ATE422880T1
ATE422880T1 AT04809612T AT04809612T ATE422880T1 AT E422880 T1 ATE422880 T1 AT E422880T1 AT 04809612 T AT04809612 T AT 04809612T AT 04809612 T AT04809612 T AT 04809612T AT E422880 T1 ATE422880 T1 AT E422880T1
Authority
AT
Austria
Prior art keywords
conjugates
glycerol
polyethylene glycol
compositions
heterofunctional
Prior art date
Application number
AT04809612T
Other languages
English (en)
Inventor
Francis Ignatious
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE422880T1 publication Critical patent/ATE422880T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08Saturated oxiranes
    • C08G65/10Saturated oxiranes characterised by the catalysts used
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48Polymers modified by chemical after-treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
AT04809612T 2003-08-26 2004-08-25 Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen ATE422880T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49780203P 2003-08-26 2003-08-26

Publications (1)

Publication Number Publication Date
ATE422880T1 true ATE422880T1 (de) 2009-03-15

Family

ID=34465064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04809612T ATE422880T1 (de) 2003-08-26 2004-08-25 Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen

Country Status (7)

Country Link
US (1) US7196145B2 (de)
EP (1) EP1663171B9 (de)
JP (1) JP2007503514A (de)
AT (1) ATE422880T1 (de)
DE (1) DE602004019546D1 (de)
ES (1) ES2321841T3 (de)
WO (1) WO2005037911A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006069782A2 (en) 2004-12-27 2006-07-06 Silence Therapeutics Ag. Lipid complexes coated with peg and their use
MXPA06012722A (es) 2004-05-05 2007-02-14 Atugen Ag Lipidos, complejos de lipido y su uso.
HUE056941T2 (hu) 2004-12-22 2022-04-28 Nitto Denko Corp Gyógyszerhordozó és gyógyszerhordozó kit fibrózis gátlására
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
JP4992090B2 (ja) * 2005-05-02 2012-08-08 国立大学法人 東京大学 静電結合型高分子ベシクル
WO2006130978A1 (en) 2005-06-06 2006-12-14 The University Of British Columbia Polymer-based serum albumin substitute
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
KR101670085B1 (ko) * 2006-07-21 2016-10-28 사일런스 테라퓨틱스 게엠베하 단백질 키나아제 3의 발현을 억제하기 위한 수단
AU2007319836A1 (en) * 2006-11-14 2008-05-22 The Trustees Of The University Of Pennsylvania Efficient nuclear delivery of antisense oligonucleotides
JP5515224B2 (ja) * 2007-02-28 2014-06-11 日油株式会社 多分岐鎖ポリオキシアルキレン誘導体
TWI407971B (zh) 2007-03-30 2013-09-11 日東電工股份有限公司 Cancer cells and tumor-related fibroblasts
US8506993B2 (en) * 2007-08-14 2013-08-13 University Of Houston Compositions and methods for making and using multifunctional polymerized liposomes
CN101970012A (zh) * 2007-09-14 2011-02-09 日东电工株式会社 药物载体
US20110281934A1 (en) * 2008-11-06 2011-11-17 Phaserx, Inc. Micelles of hydrophilically shielded membrane-destabilizing copolymers
US8969473B2 (en) * 2009-02-21 2015-03-03 Sofradim Production Compounds and medical devices activated with solvophobic linkers
JP5502349B2 (ja) * 2009-03-13 2014-05-28 出光興産株式会社 水系潤滑剤
JPWO2011043061A1 (ja) * 2009-10-05 2013-03-04 キヤノン株式会社 光音響イメージング用造影剤、及び、それを用いた光音響イメージング方法
US8359883B2 (en) * 2009-11-13 2013-01-29 Hasmukh Dholakiya Gemstone setting
DE102009059104A1 (de) * 2009-12-18 2011-06-22 Johannes-Gutenberg-Universität Mainz, 55122 Funktionelle verzweigte Polyether Copolymere sowie Verfahren zu ihrer Herstellung
BR112012021991A2 (pt) * 2010-03-01 2020-09-01 The University Of British Columbia policlicerol hiperramificado uso de um poliglicerol hipermanificado, método de adiministração de uma força biologicamente ativa a um tecido biológico, composição farmacêutica e método de síntese de um poliglicerol hiperrramificado.
JP5949037B2 (ja) 2011-03-30 2016-07-06 日油株式会社 末端に複数の水酸基を有するポリオキシエチレン誘導体
KR101483786B1 (ko) * 2011-05-27 2015-01-21 한국과학기술원 가지형 폴리에틸렌글리콜을 이용한 초자성나노입자의 용매 치환 방법 및 그 제조물
US9919059B2 (en) * 2012-12-10 2018-03-20 Massachusetts Institute Of Technology Multistage nanoparticle drug delivery system for the treatment of solid tumors
EP3237488A1 (de) * 2014-12-18 2017-11-01 Université de Bordeaux Polymerteilchen und biomaterialien damit
WO2016123107A1 (en) * 2015-01-28 2016-08-04 The Administrators Of The Tulane Educational Fund Nanoparticle polymer grafted dispersants and unimolecular micelles and methods of use
KR101607849B1 (ko) 2015-11-10 2016-03-31 영남대학교 산학협력단 생분해성 고분자 필름 및 그 제조방법
JP7019201B2 (ja) * 2016-08-02 2022-02-15 キュリアールエックス インコーポレーテッド リポソームの調製方法
DE102016119102A1 (de) * 2016-10-07 2018-04-12 Forschungszentrum Jülich GmbH Translokation von synthetischen Polymeren durch Lipidmembrane
AU2017438994A1 (en) * 2017-11-09 2020-05-28 Immunovaccine Technologies Inc. Pharmaceutical compositions, methods for preparation comprising sizing of lipid vesicle particles, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4762915A (en) * 1985-01-18 1988-08-09 Liposome Technology, Inc. Protein-liposome conjugates
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
JP2593032B2 (ja) * 1992-02-07 1997-03-19 新技術事業団 両末端ヘテロ官能性ポリエーテル並びに該ポリエーテルを製造する方法及び重合開始剤
PT627940E (pt) 1992-03-05 2003-07-31 Univ Texas Utilizacao de imunoconjugados para o diagnostico e/ou terapia de tumores vascularizados
US5395619A (en) 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
JP3465307B2 (ja) * 1993-08-05 2003-11-10 日本油脂株式会社 ポリアルキレンオキシド誘導体および製造方法
CA2269758C (en) 1996-10-22 2008-01-08 Hermes Biosciences, Inc. Liposome compositions comprising ionizable compounds in stable precipitated form and methods for their preparation
KR20010015856A (ko) * 1997-12-12 2001-02-26 마크로메드 인코퍼레이션 단백질 변성용으로 헤테로 작용기를 가진 별 모양의폴리(에틸렌글리콜)
US7244826B1 (en) 1998-04-24 2007-07-17 The Regents Of The University Of California Internalizing ERB2 antibodies
KR100679906B1 (ko) 1998-09-16 2007-02-07 알자 코포레이션 리포솜-엔트랩된 토포이소머라제 억제제
ATE274016T1 (de) * 1998-12-22 2004-09-15 Bayer Materialscience Ag Verfahren zur herstellung von hochverzweigten polyolen auf der basis von glycidol
US6765082B2 (en) * 1998-12-22 2004-07-20 Bayer Aktiengesellschaft Method for producing highly-branched glycidol-based polyols
US7009033B2 (en) * 2001-07-02 2006-03-07 Polymer Source Inc. Heterofunctional polyethylene glycol and polyethylene oxide, process for their manufacture

Also Published As

Publication number Publication date
EP1663171B9 (de) 2009-08-19
EP1663171B1 (de) 2009-02-18
US20050048650A1 (en) 2005-03-03
JP2007503514A (ja) 2007-02-22
EP1663171A2 (de) 2006-06-07
US7196145B2 (en) 2007-03-27
ES2321841T3 (es) 2009-06-12
WO2005037911A2 (en) 2005-04-28
EP1663171A4 (de) 2006-10-18
WO2005037911A3 (en) 2006-03-30
DE602004019546D1 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
ATE422880T1 (de) Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen
HRP20070268A2 (en) Site-directed modification of fviii
AU2003303458A1 (en) Ampholytic copolymer and use thereof
DE502004010014D1 (de) Anionische ampholytische copolymere
CY1110602T1 (el) Φαρμακευτικες συνθεσεις υπο μορφη γελης ή διαλυματος με βαση τη διυδροτεστοστερονη, μεθοδοι παρασκευης και χρησεις τους
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
DK1799748T3 (da) Bionedbrydelige kationiske polymerer
WO2011079279A3 (en) Nanoconjugates and nanoconjugate formulations
BRPI0414017A8 (pt) pró-fármacos poliméricos de múltiplos braços
TW200631604A (en) Ophthalmic compositions comprising polyether substituted polymers
ATE496626T1 (de) Komprimierte pharmazeutische zusammensetzungen mit peg und elektrolyten
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
DE60206512D1 (de) Rapanycin29-enole
AR051611A1 (es) Composiciones de polimeros y copolimeros de poliester que contienen particulas metalicas de titanio
WO2006132647A3 (en) Antimicrobial copolymers and uses thereof
NO20032211D0 (no) Pulverbelegg med lav glans
EA200700435A1 (ru) Рентгеноконтрастные полимерные стенты
DE60326150D1 (de) Anisinsäure und Glyceride enthaltende Zusammensetzungen
BR0209440A (pt) Sulfonamidas
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
EA200801343A1 (ru) Иммуноглобулины, направленные против nogo
ATE282411T1 (de) Eisenverbindungen
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
NO20033701D0 (no) Stabilisatorsammensetning for halogenerte polymerer, deres anvendelse og polymerer omfattende slike sammensetninger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties